• Novartis has hired a Goldman Sachs investment banker as its CFO. [CNBC]

• Pfizer will be presenting several studies at ASCO, including data for figitumumab, a fully-human monoclonal antibody against Insulin-like Growth Factor type 1 receptor (IGF-1R) in development for squamous cell lung cancer. [Yahoo!Finance]

• Pfizer has reported a possible data breach that occurred March 26th when an employee left a backup hard drive in a box that was later discarded in the trash. [TheDay]

• Lundbeck says it’s not interested in buying Elan. [Reuters]

• Astellas Pharma has reported another year of profit losses, cites stronger Yen, increased R&D cost and loss of patent protection. [Reuters]

• Dendreon CEO Mitchell Gold is predicting an FDA approval for Provenge. [Reuters UK]

• Finally, China is investing $9.2B in biotech, new technology. [BioSpace]

Image from patentdocs

Related Posts